Clinical Trials Directory

Trials / Unknown

UnknownNCT03218124

Optimal Remifentanil Concentration and Thyroidectomy

Optimal Effect Site Remifentanil Concentration for Smooth Extubation After Thyroid Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of Cagliari · Academic / Other
Sex
All
Age
18 Years – 67 Years
Healthy volunteers
Not accepted

Summary

The study is aimed at determining the remifentanil effect site concentration suppressing the cough at extubation after surgical thyroidectomy, performed under remifentanil/desflurane based general anesthesia, expressed as median and 95th percentile effective dose. Possible hemodynamic instability, respiratory depression or prolongation of awakening time are also sought.

Conditions

Interventions

TypeNameDescription
OTHERRemifentanil Effect site concentrationAfter skin suture, a predetermined Effect site remifentanil concentration will be achieved. Starting from 1.5 ng/ml in the first patient and increased or decreased by 0.2 ng/ml intervals based on the previous patient response: up if cough present, down otherwise ("Dixon's up and down" method).

Timeline

Start date
2017-10-01
Primary completion
2018-06-01
Completion
2018-07-01
First posted
2017-07-14
Last updated
2017-07-14

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT03218124. Inclusion in this directory is not an endorsement.